Newborn Screening for Cystic Fibrosis

Newborn Screening for Cystic Fibrosis


English[eng]


newborn screening||immunoreactive trypsin(ogen)||dried blood spot||radioimmunoassay||DNA||cystic fibrosis||incidence||malnutrition||cost||health policy||CF transmembrane conductance regulator-related metabolic syndrome||CF screen positive||inconclusive diagnosis||DNA analysis||next generation sequencing||extended genetic analysis||presumptive diagnosis||sweat test||parental information||newborn bloodspot screening||psychological impact||biochemical screening||pancreatitis associated protein||immunoreactive trypsinogen||cystic fibrosis screen positive||inconclusive diagnosis (CFSPID)||bioethics||newborn screen||target disorder||missed case||sensitivity||CFSPID||immunoreactive trypsin||meconium ileus||diagnosis||therapy||prognosis||n/a